EUA
RapCov Rapid COVID-19 Test
FDA Emergency Use Authorization · ADVAITE, Inc. · Apr 26, 2021
Key facts
| Product | RapCov Rapid COVID-19 Test |
|---|---|
| Company | ADVAITE, Inc. |
| Product type | IgG, Lateral Flow, Fingerstick Whole Blood |
| Date | Apr 26, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: